OR WAIT null SECS
March 21, 2022
FDA has approved ZTALMY as a treatment for seizures associated with CDKL5 deficiency disorder (CDD).
AstraZeneca’s antibody combination has been authorized for use in Great Britain to prevent COVID-19 in high-risk populations and people for whom vaccination may not be effective.
Moderna has reached an agreement with the Ministry of Health, Labor, and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of its COVID-19 Booster Vaccine.
Olympia Pharmacy is voluntarily recalling eleven lots of seven compounded products due to out-of-specification results.
Moderna, Pfizer, and BioNTech are seeking FDA approval for a fourth dose of their respective COVID-19 vaccines.
physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.
March 18, 2022
New report released by USP offers a look into API supply-chain vulnerabilities.
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
Emmes has acquired Casimir, marking its fourth major acquisition.
Sanofi and Seagen have entered an agreement to investigate three cancer targets.